Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer

BACKGROUND: A significant gap in pancreatic ductal adenocarcinoma (PDAC) patient's care is the lack of molecular parameters characterizing tumours and allowing a personalized treatment. METHODS: Patient-derived xenografts (PDX) were obtained from 76 consecutive PDAC and classified according to...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicolle, Rémy, Blum, Yuna, Duconseil, Pauline, Vanbrugghe, Charles, Brandone, Nicolas, Poizat, Flora, Roques, Julie, Bigonnet, Martin, Gayet, Odile, Rubis, Marion, Elarouci, Nabila, Armenoult, Lucile, Ayadi, Mira, de Reyniès, Aurélien, Giovannini, Marc, Grandval, Philippe, Garcia, Stephane, Canivet, Cindy, Cros, Jérôme, Bournet, Barbara, Moutardier, Vincent, Gilabert, Marine, Iovanna, Juan, Dusetti, Nelson, Buscail, Louis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334821/
https://www.ncbi.nlm.nih.gov/pubmed/32629389
http://dx.doi.org/10.1016/j.ebiom.2020.102858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334821/
https://www.ncbi.nlm.nih.gov/pubmed/32629389
http://dx.doi.org/10.1016/j.ebiom.2020.102858

Ejemplares similares